Linezolid: effectiveness and safety for approved and off-label indications. - Wikidata - wikimedia - TriplyDB

Linezolid: effectiveness and safety for approved and off-label indications.

Linezolid: effectiveness and safety for approved and off-label indications.

http://www.wikidata.org/entity/Q36967288

about

Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants.Looking toward basic science for potential drug discovery targets against community-associated MRSA Pharmacoeconomics of linezolid.Linezolid for the treatment of drug-resistant infections.Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review.Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin.

P2860

Q33420904-50A98340-E79A-4B34-B208-833A02560E44 Q33560722-10B58E86-6C43-47A5-A60E-94C306180870 Q34765976-DBD14EC1-C140-4091-BC45-8FEA63DA4635 Q34894133-D48D0488-24BB-4F53-88EF-36415AA2BD76 Q35568367-7985EC1D-2C50-472B-B8CB-831C4C51BC9E Q37463209-F0121A56-38CF-41C1-916C-B59E2A07B591 Q38075466-836B00EA-5B18-4043-BF5E-02F9A839A96F Q38777085-5F7B3230-89CA-45BC-ADDC-E4DE886770CA Q38892589-C7B80494-73E2-4E07-9610-F7DC47290A94 Q42544277-559F43A8-F720-4C46-AF0B-2D9439B36048 Q42869521-292FFD23-CF24-4E08-9013-EEB5BCDE1BCC

P2860

Linezolid: effectiveness and safety for approved and off-label indications.

http://www.wikidata.org/entity/Q36967288

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Linezolid: effectiveness and safety for approved and off-label indications.

@en

type

label

Linezolid: effectiveness and safety for approved and off-label indications.

@en

prefLabel

Linezolid: effectiveness and safety for approved and off-label indications.

@en

P1433

Q36967288-FF30B5BB-59B3-4662-B2F2-41A165BF581B

P1476

Q36967288-DB158200-07AA-4325-B4ED-78AB2ED601A0

P2093

Q36967288-90AFB0BF-EE18-4937-9C0A-C128FB125CFA

P2860

Q36967288-0035B6DA-AEDE-4586-9629-6B331EC953F0

Q36967288-053361AB-D621-48E1-92CD-6C13DBB8A4A7

Q36967288-081D5B6C-0E62-4186-AD42-1366DD4E6B85

Q36967288-0EC1CC2C-23B7-4392-B327-6CE97CCBED00

Q36967288-10981530-BEAD-449A-BD1E-D23F9D2294D7

Q36967288-120018A2-1C91-45EC-9E1E-21F0DD4DD222

Q36967288-129E9439-1BAD-4165-9DF4-8B437422C81B

Q36967288-143F085B-896B-418E-816F-37FD35A10133

Q36967288-1A4AF396-4B57-4FF7-97F4-32C20D635862

Q36967288-1A578CD8-1306-4CEC-9B4B-8505AFF23C26

P304

Q36967288-853B03C6-2FF6-4F74-AF9E-E55D2F6A5CBA

P31

Q36967288-6F655C59-B9A1-4106-A2FD-2E82043EFE9D

P356

Q36967288-908CA3D9-B8B2-476C-BD04-1A7C3C4E9AF0

P407

Q36967288-C8EF0DC6-7540-42EA-B899-4D728BCCB895

P433

Q36967288-FC9AF65F-F64B-4B49-B83F-E85B96EA2082

P478

Q36967288-96F259CF-4A99-4684-A50A-7FF134B65341

P50

Q36967288-CB185729-A65A-4FA2-98B0-DF7C55567468

Q36967288-DB8D2DB4-5013-476E-B6C2-D9D8E9D625D0

P577

Q36967288-654F3CA2-00FA-4AA8-AD54-AF71C2483492

P698

Q36967288-3DE72308-7C76-4520-BC4C-3940183398B8

P356

14656566.8.14.2381

P1433

Expert Opinion on Pharmacotherapy

P1476

Linezolid: effectiveness and safety for approved and off-label indications.

@en

P2093

Fotinie Ntziora

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of the oxazolidinone antibacterial agents

Oxazolidinones: a review

A comparative study on the cost of new antibiotics and drugs of other therapeutic categories

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

Efficacy of linezolid in a staphylococcal endocarditis rabbit model.

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.

Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.

Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.

A review of linezolid: the first oxazolidinone antibiotic.

P304

2381-2400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.8.14.2381

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Konstantinos Z Vardakas

Matthew E. Falagas

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17927491

http://www.w3.org/2001/XMLSchema#string